Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide
KCTD17
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN978857
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 22 jours ouvrables
Aperçu rapide pour Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide (ABIN978857)
Antigène
KCTD17
(Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- YGSEDQAEFL CVVSKELHST PNGLSSESSR KTKSTEEQLE EQQQQEEEVE
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-KCTD17 Antibody(ARP35359_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))
-
Sujet
-
The function of this protein remains unknown.
Alias Symbols: FLJ12242
Protein Interaction Partner: AQP1,KCTD17,LNX1,LRRC18,NIF3L1,NUDT18,PSMA1,RWDD4,STK16,TUBGCP4,AQP1,KCTD17,LNX1,LRRC18,NIF3L1,NUDT18,PSMA1,RWDD4,STK16,TUBGCP4
Protein Size: 290 -
Poids moléculaire
- 32 kDa
-
ID gène
- 79734
-
NCBI Accession
- NM_024681, NP_078957
-
UniProt
- Q8N5Z5
Antigène
-
Vous êtes ici:
